Neuraxis, Inc. /
Masimo Corporation
Neuraxis takes back Masimo Bridge-related products and assets
What happened
Neuraxis, Inc. agreed to pay Masimo Corporation $200,000 for products and related assets, the licensed trademark, and patents related to the products. The payment is scheduled in two equal installments, due Dec. 31, 2025, and June 30, 2026.
The assets relate to the NSS-2 Bridge, a percutaneous nerve field stimulator indicated for use in reducing symptoms of opioid withdrawal.
The source
Everything on this page comes from the source below.
Neuraxis takes back Masimo Bridge-related products and assets
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verifiedAlso stated
The source this page is built from.
Source-verifiedAlso stated
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly